Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics

NCT05692596 is registered in ClinicalTrials.gov with H. Lee Moffitt Cancer Center and Research Institute as lead sponsor.

NCT NCT05692596
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05692596 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics
Lead sponsor
H. Lee Moffitt Cancer Center and Research Institute
Phase
Observational
Overall status
Active, not recruiting
Start date
October 6, 2022
Completion date
July 31, 2027
Enrollment
317 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ataxia telangiectasia, brca mutation, chronic pancreatitis, familial atypical multiple mole-melanoma, fap, fatty pancreas, genetic pancreatic cancer, genetic pancreatitis, lynch syndrome, palb2 gene mutation, pancreatic cyst, pancreatic ductal adenocarcinoma, peutz-jeghers syndrome